Publicaciones en colaboración con investigadores/as de Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (30)

2024

  1. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

    Kidney International Reports

  2. Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

    Annals of the Rheumatic Diseases

2023

  1. Corrigendum to ‘Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus’ [J. Autoimmun. 136 (April 2023) 103025] (Journal of Autoimmunity (2023) 136, (S0896841123000343), (10.1016/j.jaut.2023.103025))

    Journal of Autoimmunity

  2. Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 136

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Frequency and Longitudinal Course of Motor Signs in Genetic Frontotemporal Dementia

    Neurology, Vol. 99, Núm. 10, pp. E1032-E1044

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. The Effect of Body Fat Distribution on Systemic Sclerosis

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2021

  1. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Nature Communications, Vol. 12, Núm. 1

  2. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

    Journal of Clinical Investigation, Vol. 131, Núm. 23

  3. Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology

    Arthritis & rheumatology (Hoboken, N.J.), Vol. 73, Núm. 7, pp. 1288-1300

  4. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085

  5. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

  6. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Discovering new metabolite alterations in primary sjögren's syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 179

  2. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1218-1226

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  2. Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 4, pp. 529-538

  3. Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases

    Journal of Clinical Medicine, Vol. 8, Núm. 9

  4. Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 162, pp. 82-90